chrisvoncsefalvay/vaers-outcomes huggingface dataset:
found several blood clots in her lungs; it (difficulty breathing) became worse; difficulty breathing; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PULMONARY EMBOLISM (found several blood clots in her lungs) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced DYSPNOEA (difficulty breathing). On 05-Apr-2021, the patient experienced CONDITION AGGRAVATED (it (difficulty breathing) became worse). On 07-Apr-2021, the patient experienced PULMONARY EMBOLISM (found several blood clots in her lungs) (seriousness criteria hospitalization and medically significant). The patient was hospitalized from 07-Apr-2021 to 11-Apr-2021 due to PULMONARY EMBOLISM. On 15-Apr-2021, DYSPNOEA (difficulty breathing) and CONDITION AGGRAVATED (it (difficulty breathing) became worse) had resolved. At the time of the report, PULMONARY EMBOLISM (found several blood clots in her lungs) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Apr-2021, COVID-19: negative (Negative) Test results came back negative on 06Apr2021. On 07-Apr-2021, X-ray: abnormal (abnormal) Blood clots in lungs.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       After x-ray at urgent care on 07-Apr-2021 showed several blood clots in lungs, the patient was taken to the ER (emergency room) and was subsequently admitted to the hospital.  Treatment information was not provided.  On 12-Apr-2021 the patient went to their PCP (primary care physician) who stated that the clots most likely were not due to the vaccination and that the 2nd dose was safe for her to receive. At the time of this report on 15-Apr-2021, the patient reported feeling fine.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events 1-3 days after the vaccination, a causal relationship cannot be excluded. Very limited information regarding these events has been provided at this time. Further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events 1-3 days after the vaccination, a causal relationship cannot be excluded. Very limited information regarding these events has been provided at this time. Further information has been requested.
Swollen, red right thigh and painful X 72-96 hours. No treatment except warm soaks.
patient reports rash on arm developed starting at the elbow and worked its way up to the armpit
Immediately following administration of vaccine, patient became diaphoretic and light headed.  Approx 15 min post vaccine patient began complaining about abdominal pain and had emesis x2.  Patient taken to ED for further evaluation.
Pt. with brief (< 1 minute) syncopal episode after receiving GARDASIL.  Had been given HEP A & HEP B prior to GARDASIL.
Narrative: Admission Diagnosis:COVID-19 pneumonia, COPD exacerbation DIAGNOSIS: Primary Diagnosis: Pneumonia Secondary diagnosis: COVID-19, dyspnea, COPD
Patient presented for their second dose of COVID vaccine.  Patient did not have his card present at time of visit but stated that he was due for his second dose of Moderna vaccine.  At time of vaccination, MA and provider did not check patient's vaccine history.  Following vaccination it was identified that the patient had actually received Pfizer for their first vaccine dose 20 days prior.  Patient received incorrect vaccine at the incorrect interval (1 day early)
arm sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm sore) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 027A21A) for COVID-19 vaccination.     Previously administered products included for Psoriasis: Tremfaya (Not taken since 5 months).   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (arm sore). At the time of the report, VACCINATION SITE PAIN (arm sore) outcome was unknown.            No concomitant  and treatment medications were reported.    This case was linked to MOD-2021-391180 (Patient Link).
This spontaneous report as received from a Licensed Practical Nurse refers to a 5 year old of unknown gender.  Pertinent medical history and drug reactions were not reported. On 11-JUL-2014, the patient was vaccinated with VARIVAX (lot number, dose and route were not reported) and (Oka/Merck) PROQUAD (lot number, dose and route were not reported). No adverse symptoms reported. Additional information has been requested.
Chest pain, heart pain and painful heartbeats x 1 day; severe 10/10. Irretractable lower back, leg and hip pain; severe 10/10. Elevated ANA lasting 3+ weeks. Unable to sleep or move due to pain.  Anti-inflammatory and narcotics did not help pain.
painful Blisters in mouth 24 hours after lasting for 4 days, nosebleeds on second day
Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced HEADACHE (Headache). In March 2021, HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Tingling  sensation throughout body 1 hour after vaccination, followed by numbness.  1 hour and 20 minutes after the vaccination my face started swelling.
Red patch, localized area.  Patient was advised to see PCP.  Reaction occurred in area of yellow fever only.
Soreness at injection site; Extremely itchy from head to bottom of feet; Muscle spasms at injection site; Left leg felt tingly; Weird; This is a spontaneous report from a non-contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 10:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, bradycardia, tachycardia and high blood pressure. The patient was allergic to Penicillin (PCN), red dye, sulfa drugs, eel, pesticides in fruit/vegetable and too many food allergies to list. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 19Mar2021 at 10:15 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced soreness at injection site, extremely itchy from head to bottom of feet, muscle spasms at injection site, left leg felt tingly and felt weird for 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events soreness at injection site, extremely itchy from head to bottom of feet, muscle spasms at injection site, left leg felt tingly and felt weird were recovered on 10Apr2021.  No follow-up attempts are needed. No further information is expected.
Within 15 minutes after my second dose, I felt dizziness. The nurse asked me to go upside down and put cotton in my nose. Then she walked with me to the door. After the first shot, I had a headache like I never experienced before in my whole life (for one day only and then stopped). After second shot 09/27/2021, I felt very sick for around 3 days. Now after about three months, I  experience a throbbing heart and sometimes in my back. I never experienced this in my life. I never had problem with my heart before. I do not know if this is related to the vaccine or not.
chills, difficult maintina body heat in extremities (feet and hands), joint pain, boady aches, eye dryness, rash and welt the 4cm x 7 cm at injection site displaying swelling and heat, and itch. at 15 hour post injection started intermittent rounds of ibuprophen and acetaminophen. now at 43 hours post injections symptoms same and upper respirator and congestion and post nasal drip has started.
Employee states she felt "dizzy", "sweaty" and "faint" about 3 hours after being vaccinated. She also reported "seeing black spots".
Full body flushing, increased blood pressure (175/135) Increased heart rate (138), dizziness, body sweating, headache, struggle breathing.     Seen within the clinic and an ambulance called as unable to decrease heart rate and blood pressure.   Sent to ER for treatment.
Heat surrounding injection site; Swelling surrounding injection site; Redness surrounding injection site; This is spontaneous report from a non-contactable consumer, the patient. A 39-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration in the left arm on 18Mar2021 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, allergy to latex, codeine (MANUFACTURER UNKNOWN) and neomycin (MANUFACTURER UNKNOWN) both since an unknown date. Concomitant medications were not reported. The patient received unspecified vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9269), via an unspecified route of administration on 16Feb2021, (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 20:00, the patient experienced swelling, redness and heat surrounding the injection site. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of swelling surrounding injection site, redness surrounding injection site and heat surrounding injection site were not recovered at the time of this report.   No follow-up attempts possible. No further information expected.
Arm hurt badly / couldn't sleep on that arm but could use it for other things; This case was reported by a consumer and described the occurrence of pain in arm in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received first dose of Shingrix and he believed that it was administered properly into the his left deltoid. The patient was complained that arm hurt badly for 2 weeks and patient couldn't sleep on that arm but could use it for other things The patient had flu vaccine 2 weeks later in other arm.
5-10 min after administration of MMR vaccine, pt developed chest pain, became tachycardic.  Subsequently he developed cough & mild wheezing.  Given EPIPEN Jr. & ALBUTEROL treatment.  Recovered fully.  Taken to ER for observation. He had generalized erythema, pruritic rash the following day. Resolved after 1 day.
now my husband has the cough, it's just that he is not he is not blowing his nose that much, but we both had our shot on same day.; now my husband has the cough, it's just that he is not he is not blowing his nose that much, but we both had our shot on same day.; This is a spontaneous report from a contactable consumer (Reporter's husband). An 80-year-old male patient received second dose of BNT162B2 (COMIRNATY, Solution for Injection, Batch/Lot number: unknown) via unspecified route of administration on 17Mar2021 (at the age of 80-year-old) as dose 2, single for COVID-19 immunization. The patient medical history was reported as none. The patient received unspecified concomitant medications. On an unspecified date in 2021, the patient experienced now my husband has the cough, it's just that he is not he is not blowing his nose that much, but we both had our shot on same day. This is the second case out of two cases in which reporter is reporting for her husband. Reporter stated, well, we got our final shot on the 17th and I had a cold when I went in or when they called me about it, anyway when I went in, I told them I had a cold, they say no come-on in we can still give you the shot. Then when I got in there, I told them I so had cold and they checked with the pharmacist and he said that would be okay, but then I also got a cough and now my husband has the cough, it's just that he is not he is not blowing his nose that much, but we both had our shot on same day. And I don't think I have run a fever with it all. I did have a fever when they gave me the shot. And then I am just wondering if this a reaction to some of the Pfizer. Reporter added, no fever and I went in with the cold and then my husband come down with the cough now and we both got them on 17th and we got the second one. I have a cough too. When confirmed that the reporter wanted to know if this is the side effect from the Pfizer COVID 19 Vaccine, reporter stated, right. LOT: Reporter stated, I don't see a LOT over here, EN6207, this is for me, and my husband had the same one. When confirmed if it is for the Reporter or her husband, Reporter stated, this is for me, and my husband had the same one (Further clarification unknown hence not captured in tab). Expiration date: Reporter stated, I do not know what date that is. Where would that be. It just says 17MAR2021 at (name). Concomitant medication: Reporter stated, yes. Name of the medication: Reporter stated, no, I don't know them. Outcome of all the events was unknown.  No follow-up attempts were possible; information about lot/batch number cannot be obtained. No further information was expected.
Narrative:  Pt was COVID positive 7/16; was admitted to hospital; died 8/3
Red dots on feet. About 20 total between both feet. Itchy, pink, eraser size. Not pussing. Developed 9 days after vaccine. Antihistamine recommended.
Large reddened area at site of DTAP injection, (from shoulder to elbow). Site warm and tender to touch. Referred to MD.
Jan. 30 received vaccine at 9:00 by 1:00 that afternoon low grade fever 99.8, headache, chills, muscle soreness, sinus pain, cough, and my left arm really hurt.  Jan. 31,  had  same symptoms as before but fever of 102.8, continued into the night fever became 99. Monday Feb. 1 woke up on headache or fever but now had a rash at injection site and arm still hurts. Later during the day, low grade fever headache, sinus pain, and cough. Today, Feb. 2 I have rash is less and not a much pain in arm. I have low grade fever off and on through out the day and night. Feb. 3, I still have the rash headaches, sinus pain, and small cough. I do try easily .  I have not lost my appetite or sense of smell or taste.
This spontaneous report as received from a registered nurse refers to a 4 year old, child patient. The patient's medical history and past drug history were unknown. On 08-APR-2014 the patient was accidentally vaccinated once with ZOSTAVAX, (lot # J012658, expiration date 10-JAN-2015), subcutaneously in the left arm instead of PROQUAD (Merck) as prescribed. The child will not receive another dose of ZOSTAVAX. Concomitant medications were not unknown. The outcome of receiving ZOSTAVAX instead of PROQUAD (Merck) was unknown. Additional information has been requested.
Got progressively worse. Felt sleep, tired, fatigued, nausea, dizzy. By noon next day ached head to toe, fever close to 100 degrees; took aspirin.
40 hrs after vaccination - patient experienced swelling/redness of arm (left) to elbow. MD consulted and antibiotic given and BENADRYL. MD Consulted - Band-Aid not removed until reaction occurred.
Vertigo type symptoms, dizziness, nausea, light headed, low energy, off balance, blurred vision, unable to drive. Haven't been able to go to work since 4/1/2021 and have been confined to my home, need other people to drive me to Doctor's appointments and provide food, etc.
First shot 2 years ago, not advised to get a 2nd; This case was reported by a consumer and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st shot received 2 years ago from the date of reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The case was reported by patient. Age at vaccination was not applicable for this report. The patient did not received 2nd dose of Shingrix till the time of reporting which led to incomplete course of vaccination.  The patient asked that please advise on whether to get now. No contact details were available. The case had been linked with US2021AMR187247 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR187247:Same reporter. Husband's case.
Erythema and induration approximately 7x5cm on L arm and 3x4cm on R arm.
at 4:30 PM-Driving home and felt throat was slightly sore and having some problems swallowing 100% of saliva at 5:30 PM-was cooking dinner and throat was slightly numb. at 6:30 PM-throat was completely numb, with numbess coming and going in in episodes, and having difficulty swallowing.  Could swallow about 40% saliva.  Had difficulty breathing, and went to ER.
One day after vaccine had very loud ringing in mostly left ear. I had mild tinnitus before but nothing like this - significantly much louder. Made ENT appointment.  Saw the ENT yesterday - he told me I had significant hearing in left ear which he said would make the ringing louder. Very concerned vaccine caused hearing loss in left ear since tinnitus was significantly worse one day after vaccine.
Received FLUZONE at approx. 07:00. 08:00 dry cough progressing to audible wheezing with increasing severity. Treated with 25 mg BENADRYL IM with symptom improvement.
This spontaneous report was received from a registered nurse referring to a 13 year old male patient. The patient's concomitant medication, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 27-SEP-2017, the patient was vaccinated with either GARDASIL lot # N000326, expiration date 14-OCT-2019 or GARDASIL 9 lot # N000326, expiration date: not reported (strength, dose, dose number and route of administration were not provided) for prophylaxis which were improperly stored (incorrect product storage). This is one of several reports received from the same source.; Sender's Comments: US-009507513-1709USA008666:
The vial was initially stored in the refrigerator on 08-Mar-2022 and the dose was administered on 16-May-2022; Administered vaccine after the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered vaccine after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Mar-2022 and the dose was administered on 16-May-2022) in a 19-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 027L21A) for COVID-19 prophylaxis.     Patient had no known allergies to medications, food and other products, and also patient did not have any acute illness at the time of vaccination and up to one month before. Patient did not have any chronic illness or long-standing health conditions. Patient neither diagnosed with COVID-19 nor tested positive. Patient was not taking prescriptions, over the counter medications, dietary supplements, or herbal remedies at time of vaccination or at the time of the adverse event. No other vaccines received within one month prior to any dose of Moderna vaccine.    On 16-May-2022 at 11:00 AM, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 16-May-2022 at 11:00 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered vaccine after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Mar-2022 and the dose was administered on 16-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered vaccine after the 30 day beyond use date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Mar-2022 and the dose was administered on 16-May-2022) outcome was unknown.      The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.   For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   Reported that administered vaccine after the Beyond Use by Date (BUD) from  08-Mar-2022 to 01-Jun-2022. The vial was initially stored in refrigerator on 08-Mar-2022. The vial did not undergo the temperature excursion. The patient had not reported symptoms. No additional doses, medications, or treatments had been administered.
vaccinated on 06/18/2020 /  not receive the second dose yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 18th June 2020, batch number 924T3).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up. This case was linked with case US2021172402, reported by same reporter for different patient. The details were reported for 1st dose of Shingrix.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021172402:same reporter